

© 2025 LYNX-Werbemitteilung - Bitte beachten Sie den Haftungsausschluss
Realtime | Geld | Brief | Zeit |
---|---|---|---|
161,60 | 161,80 | 25.05. | |
161,20 | 161,40 | 23.05. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Key Drivers Behind AbbVie's (ABBV) Performance | ||
Fr | ABBVIE: Allergan Aesthetics' BOTOX[] (botulinum toxin type A) receives MHRA approval for the temporary improvement in the appearance of moderate to severe platysma prominence (platysma bands )[1] | ||
Do | AbbVie and U of T Mississauga's SpinUp Announce Neuropeutics Inc as First AbbVie Biotech Innovators Award Recipient | ||
Do | AbbVie (ABBV) has a Stable and Highly Profitable Business Model | ||
Di | AbbVie (ABBV) Soared on Favorable Tailwinds |